Devico AL - Search Results

1

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

Devico AL, Fouts TR, Shata MT, Kamin-Lewis R, Lewis GK, Hone DM. Devico AL, et al. Vaccine. 2002 May 6;20(15):1968-74. doi: 10.1016/s0264-410x(02)00080-4. Vaccine. 2002. PMID: 11983256 Review.

2

Beta-chemokines and protection from HIV type 1 disease.

Garzino-Demo A, DeVico AL, Cocchi F, Gallo RC. Garzino-Demo A, et al. Among authors: devico al. AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S177-84. AIDS Res Hum Retroviruses. 1998. PMID: 9672236 Review.

3

A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling.

Burns JM, Gallo RC, DeVico AL, Lewis GK. Burns JM, et al. Among authors: devico al. J Exp Med. 1998 Nov 16;188(10):1917-27. doi: 10.1084/jem.188.10.1917. J Exp Med. 1998. PMID: 9815269 Free PMC article.

4

Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling.

Burns JM, Lewis GK, DeVico AL. Burns JM, et al. Among authors: devico al. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14499-504. doi: 10.1073/pnas.96.25.14499. Proc Natl Acad Sci U S A. 1999. PMID: 10588734 Free PMC article.

5

Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.

Fouts TR, Tuskan R, Godfrey K, Reitz M, Hone D, Lewis GK, DeVico AL. Fouts TR, et al. Among authors: devico al. J Virol. 2000 Dec;74(24):11427-36. doi: 10.1128/jvi.74.24.11427-11436.2000. J Virol. 2000. PMID: 11090138 Free PMC article.

6

Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta.

Kamin-Lewis R, Abdelwahab SF, Trang C, Baker A, DeVico AL, Gallo RC, Lewis GK. Kamin-Lewis R, et al. Among authors: devico al. Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9283-8. doi: 10.1073/pnas.161298998. Epub 2001 Jul 24. Proc Natl Acad Sci U S A. 2001. PMID: 11470920 Free PMC article.

7

Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.

Finnegan CM, Berg W, Lewis GK, DeVico AL. Finnegan CM, et al. Among authors: devico al. J Virol. 2001 Nov;75(22):11096-105. doi: 10.1128/JVI.75.22.11096-11105.2001. J Virol. 2001. PMID: 11602749 Free PMC article.

8

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

Shata MT, Reitz MS Jr, DeVico AL, Lewis GK, Hone DM. Shata MT, et al. Among authors: devico al. Vaccine. 2001 Nov 12;20(3-4):623-9. doi: 10.1016/s0264-410x(01)00330-9. Vaccine. 2001. PMID: 11672930

9

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, Gallo R, Vermund SH, Louria DB. Skurnick JH, et al. J Infect Dis. 2002 Feb 15;185(4):428-38. doi: 10.1086/338830. Epub 2002 Jan 17. J Infect Dis. 2002. PMID: 11865394 Free PMC article.

10

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.

Fouts T, Godfrey K, Bobb K, Montefiori D, Hanson CV, Kalyanaraman VS, DeVico A, Pal R. Fouts T, et al. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11842-7. doi: 10.1073/pnas.182412199. Epub 2002 Aug 21. Proc Natl Acad Sci U S A. 2002. PMID: 12192089 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page